Page last updated: 2024-10-24

bupivacaine and Raynaud Disease

bupivacaine has been researched along with Raynaud Disease in 2 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Raynaud Disease: An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Şahin, ÖF1
Tarıkçı Kılıç, E1
Aksoy, Y1
Kaydu, A1
Gökçek, E1
Hashem, M1
Lewis, R1

Other Studies

2 other studies available for bupivacaine and Raynaud Disease

ArticleYear
The importance of perfusion index monitoring in evaluating the efficacy of stellate ganglion blockage treatment in Raynaud's disease.
    The Libyan journal of medicine, 2018, Volume: 13, Issue:1

    Topics: Adult; Anesthetics, Local; Autonomic Nerve Block; Bupivacaine; Female; Humans; Levobupivacaine; Male

2018
Successful long-term treatment of a patient with long-standing Raynaud's disease by an extradural bupivacaine block.
    Anaesthesia and intensive care, 2007, Volume: 35, Issue:4

    Topics: Anesthetics, Local; Bupivacaine; Female; Humans; Injections, Epidural; Middle Aged; Nerve Block; Ray

2007